Dynamic contrast-enhanced (DCE) derived transfer coefficient (k trans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 3, 2008, Pages 588-597

  Haris, Mohammad ^a   Husain, Nuzhat ^b   Singh, Anup ^c   Awasthi, Rishi ^a   Rathore, Ram Kishore Singh ^c   Husain, Mazhar ^b   Gupta, Rakesh K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Blood brain barrier; Brain tuberculoma; DCE MRI; Matrix metalloproteinase; Permeability

Indexed keywords

GELATINASE B; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN MAPPING; BRAIN PERFUSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL TUBERCULOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; ENCEPHALITIS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 9; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOMA, INTRACRANIAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 51449124024     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21491     Document Type: Article

References (58)

1. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006;1:223-236.
2. Price NM, Farrar J, Tran TT, Nguyen TH, Tran TH, Friedland JS. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol 2001;166:4223-4230.
3. Bhargava S, Tandon PN. Intracranial tuberculomas: a CT study. Br J Radiol 1980;53:935-945.
4. Gupta RK, Jena A, Sharma A, Guha DK, Khushu S, Gupta AK. MR imaging of intracranial tuberculomas. J Comput Assist Tomogr 1988;12:280-285.
5. Gupta RK, Jena A, Singh AK, Sharma A, Puri V, Gupta M. Role of magnetic resonance (MR) in the diagnosis and management of intracranial tuberculomas. Clin Radiol 1990;41:120-127.
6. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci U S A 1999;96:5657-5662.
7. Haris M, Gupta RK, Husain M, et al. Assessment of therapeutic response on serial dynamic contrast enhanced MR imaging in brain tuberculomas. Clin Radiol 2008;63:562-574.
8. Kurzepa J, Bartosik-Psujek H, Suchozebrska-Jesionek D, Rejdak K, Stryjecka-Zimmer M, Stelmasiak Z. Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Neurol Neurochir Pol 2005;39:63-67.
9. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 2004;173:5209-5218.
10. Paul R, Lorenzl S, Koedel U, et al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998;44:592-600.
11. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-629.
12. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724-7732.
13. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 1999;13:527-548.
14. Lo EH, Wang X, Cuzner ML. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 2002;69:1-9.
15. Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000;173:45-52.
16. Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 2002;6:713-719.
17. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000;106:829-838.
18. Kerbel RS. Tumur angiogenesis: past, present and the near future. Carcinogenesis 2000;21:505-515.
19. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseasese. Nature 2000;407:249-257.
20. Cerimele F, Brown LF, Bravo F, Ihler GM, Kouadio P, Arbiser JL. Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor. Am J Pathol 2003;163:1321-1327.
21. Gupta RK, Haris M, Husain N, et al. Relative cerebral blood volume is a measure of angiogenesis in brain tuberculomas. J Comput Assist Tomogr 2007;31:335-341.
22. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt A, Zagzag D. Intracranial mass lesions: dynamic contrast enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29.
23. Singh A, Haris M, Rathore DKS, et al. Quantification of physiological and hemodynamic indices using T1 dynamic contrast enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 2007;26:871-880.
24. Jackson A. Imaging microvasculature structure with contrast enhanced MRI. Br J Radiol 2003;76:159-173.
25. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891-899.
26. Mun-Bryce S, Rosenberg GA. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 1998;274:R1203-R1211.
27. Candelario-Jalil E, Taheri S, Yang Y, et al. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther 2007;323:488-498.
28. Sood RR, Taheri S, Candelario-Jalil E, Estrada EY, Rosenberg GA. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 2007;1-8.
29. Gupta RK, Kathuria M, Pradhan S. Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 1999;20:867-875.
30. Gupta RK, Husain N, Kathuria MK, Datta S, Rathore RKS, Husain M. Magnetization transfer MR imaging correlation with histopathology in intracranial tuberculomas. Clin Radiol 2001;56:656-663.
31. Gupta RK, Husain M, Vatsal DK, Kumar R, Chawla S, Husain N. Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas. Magn Reson Imaging 2002;20:375-381.
32. Gupta RK, Roy R, Dev R, et al. Finger printing of Mycobacterium tuberculosis in patients with intracranial tuberculomas by using in vivo, ex vivo and in vitro magnetic resonance spectroscopy. Magn Reson Med 1996;36:829-833.
33. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998;22:139-152.
34. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-755.
35. Machein MR, Kullmer J, Fiebich BL, Plate KH, Wamke PC. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 1999;44:732-740.
36. Haris M, Husain N, Singh A, et al. Dynamic contrast enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, micro vascular density and grading of astrocytoma. J Comput Assist Tomogr (in press).
37. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-195.
38. Harris JE, Fernandez-Vilaseca M, Elkington PTG, Horncastle DE, Graeber MB, Friedland JS. IFNγ synergizes with IL-β to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis. FASEB J 2007;21:356-365.
39. Pereira CB, Palaci M, Leite OH, Duarte AJ, Benard G. Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes Infect 2004;6:25-33.
40. Donald PR, Schoeman JF, Beyers N, et al. Concentrations of interferon γ, tumor necrosis factor α, and interleukin-1β in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis 1995;21:924-929.
41. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996;157:4159-4165.
42. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995;376:345-355.
43. Price NM, Gilman RH, Uddin J, Recavarren S, Friedland JS. Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-α dependent monocyte networks. J Immunol 2003;171:5579-5586.
44. Zhu XW, Price NM, Gilman RH, Recarvarren S, Friedland JS. Multinuleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo. J Infect Dis 2007;196:1076-1079.
45. Zeni P, Doepker E, Schulze-Topphoff U, Huewel S, Tenenbaum T, Galla HJ. MMPs contribute to TNF-α induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am J Physiol Cell Physiol 2007;293:C855-C864.
46. Lee KY, Kim EH, Yang WS, et al. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 2004;220:73-78.
47. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389.
48. Leib SL, Leppert D, Clements J, Täuber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000;68:615-620.
49. Bedell BJ, Narayana PA. Volumetric analysis of white matter, gray matter, and CSF using fractional volume analysis. Magn Reson Med 1998;39:961-999.
50. Wehrli FW. Fast-scan magnetic resonance. New York: Raven Press, 1991;12.
51. Tofts PS, Shunter B, Pope JM. Ni-DTPA doped agarose gel-a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging 1993;11:125-133.
52. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
53. Weinmann HJ, Laniado M, Mutjel W. Pharmacokinetics of Gd DTPA/dimeglumine after intravenous injection into healthy volunteers. Phys Chem Phys Med NMR 1984;16:167-172.
54. Li KL, Zhu XP, Waterton JC, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-357.
55. Rijpkema M, Kaanders JHAM, Joosten FBM, Van der Kogel AJ, Heerschap A. Quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 2001;14:457-463.
56. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
57. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980;137:679-686.
58. Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39-50.